.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Daiichi Sankyo
Dow
Novartis
QuintilesIMS
Healthtrust
UBS
Farmers Insurance
Cerilliant

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021624

« Back to Dashboard
NDA 021624 describes METHADONE HYDROCHLORIDE, which is a drug marketed by Aurolife Pharma Llc, Vistapharm, Roxane, Mallinckrodt, Mylan Institutional, The Pharmanetwork, Sandoz, Mallinckrodt Inc, West-ward Pharms Int, and Epic Pharma Llc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the METHADONE HYDROCHLORIDE profile page.

The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.

Summary for NDA: 021624

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 021624

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 021624

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHADONE HYDROCHLORIDE
methadone hydrochloride
INJECTABLE;INJECTION 021624 NDA Mylan Institutional LLC 67457-217 67457-217-20 1 VIAL, MULTI-DOSE in 1 CARTON (67457-217-20) > 20 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Queensland Health
US Department of Justice
McKinsey
Covington
Johnson and Johnson
QuintilesIMS
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot